Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
Resource Type
Article
Authors
van den Bent, Martin J ; Baumert, Brigitta ; Erridge, Sara C ; Vogelbaum, Michael A ; Nowak, Anna K ; Sanson, Marc ; Brandes, Alba Ariela ; Clement, Paul M ; Baurain, Jean Francais ; Mason, Warren P ; Wheeler, Helen ; Chinot, Olivier L ; Gill, Sanjeev ; Griffin, Matthew ; Brachman, David G ; Taal, Walter ; Rudà, Roberta ; Weller, Michael ; McBain, Catherine ; Reijneveld, Jaap ; Enting, Roelien H ; Weber, Damien C ; Lesimple, Thierry ; Clenton, Susan ; Gijtenbeek, Anja ; Pascoe, Sarah ; Herrlinger, Ulrich ; Hau, Peter ; Dhermain, Frederic ; van Heuvel, Irene ; Stupp, Roger ; Aldape, Ken ; Jenkins, Robert B ; Dubbink, Hendrikus Jan ; Dinjens, Winand N M ; Wesseling, Pieter ; Nuyens, Sarah ; Golfinopoulos, Vassilis ; Gorlia, Thierry ; Wick, Wolfgang ; Kros, Johan M
Source
In The Lancet 7-13 October 2017 390(10103):1645-1653
Subject
Primary Research Articles
Language
ISSN
0140-6736